Skip to content

The Impact of Routine Measurement of Cardiac Troponin (hsTnT) on Outcome in Elderly Patients Undergoing Major Surgery

The Impact of Routine Measurement of Cardiac Troponin (hsTnT) on Outcome in Elderly Patients Undergoing Major Surgery

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03605134
Enrollment
63
Registered
2018-07-30
Start date
2018-08-23
Completion date
2019-08-07
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly, Mortality, Surgery--Complications

Keywords

troponin, diastolic function

Brief summary

To document levels of cardiac troponin hsTnT in patients above 75y undergoing high risk surgery and the relationship between elevated levels and outcome in terms of hospital stay and 30 day mortality.

Detailed description

Elevated troponin (Tn) hsTnT levels occur as a result of myocardial damage and are used in the diagnosis of myocardial infarction (MI). However, there are multiple different causes that also result in abnormal Tn levels, such as direct myocardial-cell injury, impaired renal excretion and sepsis. Because of this, elevated Tn level is a common finding in hospitalized patients. Several studies on patients admitted to the intensive care unit (ICU) without MI show that Tn elevation is a mortality risk factor and an independent predictor of hospital mortality. Up till now it is not yet known if the routine measurement of Tn in elderly patients undergoing surgery can significantly improve their outcome and that is the primary aim of this study. In addition, it is not known what the impact could be if a diastolic function assessment could be performed peri-operatively. This study will examine the correlation between elevated Tn levels in elderly patients undergoing major surgery and their short-term outcome (in-hospital). Before and immediately after surgery, diastolic function will be assessed by means of transthoracic echocardiography (TTE).

Interventions

DIAGNOSTIC_TESTlevel of cardiac troponin

blood test

transthoracic echocardiography

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
75 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* All patients ≥75 y undergoing elective and major surgery till we have collected an entire dataset of 100 patients. * Only those patients will be included who are planned for elective and major surgery.

Exclusion criteria

* Patients under the age of 75 * Intraoperative mortality * Eye surgery * Cardiac or thoracic surgery * Patients undergoing surgery which is not withheld as major surgery * For patients undergoing multiple surgeries for the same indication and during the same hospitalization, only the first surgery will be included

Design outcomes

Primary

MeasureTime frameDescription
surgical mortality30 days30 days mortality

Secondary

MeasureTime frameDescription
diastolic function3 daystransthoracic echocardiography

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026